EMERGING MARKETS NEWS

• Roche global sales flat at 2%, China faces ongoing biosimilar erosion

  2023-02-03

• MSD enjoys 22% global growth, 20% China increase in strong year

  2023-02-03

• Takeda Q3 2022: USD 23.9b in revenues, driven by core assets

  2023-02-03

• Legend Bio posts USD 55m in Q4 sales for Carvykti

  2023-02-03

• MSD soars 22% globally, 18% in Latin America, gears up for Keytruda copycats

  2023-02-03

• MSD soars 22% globally, 18% in Latin America, gears up for Keytruda copycats

  2023-02-03

CLIENTS WE SERVE